相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations
Fenghuang Xu et al.
IMMUNOLOGIC RESEARCH (2017)
Dual Roles of IL-27 in Cancer Biology and Immunotherapy
Marina Fabbi et al.
MEDIATORS OF INFLAMMATION (2017)
Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity
Jeongsu Do et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27
Alessandra Dondero et al.
ONCOTARGET (2017)
IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm
James P. White
TRANSLATIONAL CANCER RESEARCH (2017)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
Kristine Pettersen et al.
SCIENTIFIC REPORTS (2017)
Crosstalk between different family members: IL27 recapitulates IFNγ responses in HCC cells, but is inhibited by IL6-type cytokines
Catherine Rolvering et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Jian-Hong Zhong et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2017)
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
James J. Harding et al.
CANCER (2016)
Interleukin-30 Promotes Breast Cancer Growth and Progression
Irma Airoldi et al.
CANCER RESEARCH (2016)
An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
Hasita Horlad et al.
CANCER SCIENCE (2016)
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
Andy J. Minn et al.
CELL (2016)
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
Thomas R. Flint et al.
CELL METABOLISM (2016)
Combinatorial immunotherapy strategies for hepatocellular carcinoma
Maria Tagliamonte et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
The untold story of IFN-γ in cancer biology
M. Alper Kursunel et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells
Xiaotong Zhu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
Lewis Zhichang Shi et al.
NATURE COMMUNICATIONS (2016)
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
Andrea Petretto et al.
ONCOTARGET (2016)
Ly6Chi monocytes regulate T cell responses in viral hepatitis
Jiangao Zhu et al.
JCI INSIGHT (2016)
Potential clinical application of interleukin-27 as an antitumor agent
Takayuki Yoshimoto et al.
CANCER SCIENCE (2015)
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Christelle Bahlawane et al.
CELL COMMUNICATION AND SIGNALING (2015)
The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity
Samadhi Aparicio-Siegmund et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
Charles E. Egwuagu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity
Kiyoshi Hirahara et al.
IMMUNITY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
Claire Vanpouille-Box et al.
VACCINE (2015)
IL-27 induces the expression of IDO and PD-L1 in human cancer cells
Grazia Carbotti et al.
ONCOTARGET (2015)
Interleukin-30 Expression in Prostate Cancer and Its Draining Lymph Nodes Correlates with Advanced Grade and Stage
Serena Di Meo et al.
CLINICAL CANCER RESEARCH (2014)
Side Effects of Cytokines Approved for Therapy
Brian A. Baldo
DRUG SAFETY (2014)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Role of interleukin-6 in cachexia: therapeutic implications
Aditi A. Narsale et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2014)
An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer
Christoph Garbers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas
Julie Gonin et al.
PLOS ONE (2013)
IL-27 in tumor immunity and immunotherapy
Gopal Murugaiyan et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
Alexander Swarbrick et al.
ONCOIMMUNOLOGY (2013)
In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis
Su-Jin Moon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1
Kiyoshi Hirahara et al.
IMMUNITY (2012)
IL-27 Production and STAT3-Dependent Upregulation of B7-H1 Mediate Immune Regulatory Functions of Liver Plasmacytoid Dendritic Cells
Benjamin M. Matta et al.
JOURNAL OF IMMUNOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Immunomodulatory cytokines as therapeutic agents for melanoma
Courtney Nicholas et al.
IMMUNOTHERAPY (2011)
IL-27 renders DC immunosuppressive by induction of B7-H1
Svetlana Karakhanova et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
Federica Toffalini et al.
BLOOD (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses
Caroline Schoenherr et al.
CELL COMMUNICATION AND SIGNALING (2010)
IL-35-mediated induction of a potent regulatory T cell population
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2010)
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Jacqueline Bromberg et al.
CANCER CELL (2009)
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Julia Bollrath et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
Masahiro Matsui et al.
CANCER RESEARCH (2009)
Interleukin-27 Displays Interferon-γ-Like Functions in Human Hepatoma Cells and Hepatocytes
Herdis Bender et al.
HEPATOLOGY (2009)
Hypoxia-Inducible Factor 1α Is Up-Regulated by Oncostatin M and Participates in Oncostatin M Signaling
Stefan Vollmer et al.
HEPATOLOGY (2009)
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
Rosalba Salcedo et al.
JOURNAL OF IMMUNOLOGY (2009)
The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling
Sandrine Crabe et al.
JOURNAL OF IMMUNOLOGY (2009)
Interleukin 27: a double-edged sword for offense and defense
Hiroki Yoshida et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
Peng Hu et al.
MOLECULAR IMMUNOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production
Toshiyuki Owaki et al.
JOURNAL OF IMMUNOLOGY (2008)
Antiproliferative activity of IL-27 on melanoma
Takayuki Yoshimoto et al.
JOURNAL OF IMMUNOLOGY (2008)
FactoMineR: An R package for multivariate analysis
Sebastien Le et al.
JOURNAL OF STATISTICAL SOFTWARE (2008)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IL-27-Mediated activation of natural killer cells and inflammation produced antitumour effects for human oesophageal carcinoma cells
L. Liu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
IL-27 inhibits the development of regulatory T cells via STAT3
Magdalena Huber et al.
INTERNATIONAL IMMUNOLOGY (2008)
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
Jason S. Stumhofer et al.
NATURE IMMUNOLOGY (2007)
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells
Denise C. Fitzgerald et al.
NATURE IMMUNOLOGY (2007)
Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27
Christine Brender et al.
BLOOD (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1
Clemens Neufert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
Ahjoku Amadi-Obi et al.
NATURE MEDICINE (2007)
A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background
Claude Haan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Two-sided roles of IL-27:: Induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-Induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism
Takeru Yoshimura et al.
JOURNAL OF IMMUNOLOGY (2006)
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system
Jason S. Stumhofer et al.
NATURE IMMUNOLOGY (2006)
A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays
Mathias Hampf et al.
ANALYTICAL BIOCHEMISTRY (2006)
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
Marcel Batten et al.
NATURE IMMUNOLOGY (2006)
Antiangiogenic and antitumor activities of IL-27
Motomu Shimizu et al.
JOURNAL OF IMMUNOLOGY (2006)
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma
Shuntaro Oniki et al.
CANCER RESEARCH (2006)
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib
M Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients
JP Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
IL-27 limits IL-2 production during Th1 differentiation
AV Villarino et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors:: Role for CD8+ T cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2004)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms
S Lucas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-Bet and IL-12Rβ2 in naive T cells
L Hibbert et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-Bet through activation of STAT1 during initial Th1 commitment
A Takeda et al.
JOURNAL OF IMMUNOLOGY (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Inhibition of methylcholanthrene-induced carcinogenesis by an interferon γ receptor-dependent foreign body reaction
ZH Qin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4+ T cells
S Pflanz et al.
IMMUNITY (2002)
Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor
S Eyckerman et al.
FEBS LETTERS (2000)
分享论文
